An association study of DRD2 gene polymorphisms with schizophrenia in a Chinese Han population

Neuroscience Letters

Volumn 477, Issue 2, 2010, Pages 53-56

  Fan, Hua ^a   Zhang, Fuquan ^b   Xu, Yong ^b,c   Huang, Xuezhu ^b   Sun, Gaoxiang ^b   Song, Yuqing ^d   Long, Haiyin ^a   Liu, Pozi ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b TSINGHUA UNIVERSITY   (China)

^c SHANXI MEDICAL UNIVERSITY   (China)

^d PEKING UNIVERSITY SIXTH HOSPITAL   (China)

Author keywords

DRD2; Rs6277; Schizophrenia

Indexed keywords

DOPAMINE 2 RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RISK; SCHIZOPHRENIA; YOUNG ADULT;

EID: 77953292719     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.11.017     Document Type: Article

References (28)

1. Allen N.C., Bagade S., McQueen M.B., Ioannidis J.P., Kavvoura F.K., Khoury M.J., Tanzi R.E., Bertram L. Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat. Genet. 2008, 40:827-834.
2. Arinami T., Itokawa M., Enguchi H., Tagaya H., Yano S., Shimizu H., Hamaguchi H., Toru M. Association of dopamine D2 receptor molecular variant with schizophrenia. Lancet 1994, 343:703-704.
3. Duan J., Wainwright M.S., Comeron J.M., Saitou N., Sanders A.R., Gelernter J., Gejman P.V. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum. Mol. Genet. 2003, 12:205-216.
4. Dudbridge F. Likelihood-based association analysis for nuclear families and unrelated subjects with missing genotype data. Hum. Hered. 2008, 66:87-98.
5. Faul F., Erdfelder E., Lang A.G., Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 2007, 39:175-191.
6. Glatt S.J., Faraone S.V., Lasky-Su J.A., Kanazawa T., Hwu H.G., Tsuang M.T. Family-based association testing strongly implicates DRD2 as a risk gene for schizophrenia in Han Chinese from Taiwan. Mol. Psychiatry 2009, 14:885-893.
7. Glatt S.J., Faraone S.V., Tsuang M.T. Meta-analysis identifies an association between the dopamine D2 receptor gene and schizophrenia. Mol. Psychiatry 2003, 8:911-915.
8. Glatt S.J., Jonsson E.G. The Cys allele of the DRD2 Ser311Cys polymorphism has a dominant effect on risk for schizophrenia: evidence from fixed- and random-effects meta-analyses. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2006, 141B:149-154.
9. Goldman-Rakic P.S., Muly E.R., Williams G.V. D(1) receptors in prefrontal cells and circuits. Brain Res. Brain Res. Rev. 2000, 31:295-301.
10. Gonzalez-Maeso J., Ang R.L., Yuen T., Chan P., Weisstaub N.V., Lopez-Gimenez J.F., Zhou M., Okawa Y., Callado L.F., Milligan G., Gingrich J.A., Filizola M., Meana J.J., Sealfon S.C. Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature 2008, 452:93-97.
11. Gosso M.F., de G.E., Polderman T.J., Boomsma D.I., Heutink P., Posthuma D. Catechol O-methyl transferase and dopamine D2 receptor gene polymorphisms: evidence of positive heterosis and gene-gene interaction on working memory functioning. Eur. J. Hum. Genet. 2008, 16:1075-1082.
12. Gupta M., Chauhan C., Bhatnagar P., Gupta S., Grover S., Singh P.K., Purushottam M., Mukherjee O., Jain S., Brahmachari S.K., Kukreti R. Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms. Pharmacogenomics 2009, 10:277-291.
13. Hirvonen M., Laakso A., Nagren K., Rinne J.O., Pohjalainen T., Hietala J. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo. Mol. Psychiatry 2004, 9:1060-1061.
14. Hirvonen M.M., Lumme V., Hirvonen J., Pesonen U., Nagren K., Vahlberg T., Scheinin H., Hietala J. C957T polymorphism of the human dopamine D2 receptor gene predicts extrastriatal dopamine receptor availability in vivo. Prog. Neuropsychopharmacol. Bol. Psychiatry 2009, 33:630-636.
15. Jonsson E.G., Sillen A., Vares M., Ekholm B., Terenius L., Sedvall G.C. Dopamine D2 receptor gene Ser311Cys variant and schizophrenia: association study and meta-analysis. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2003, 119B:28-34.
16. Lawford B.R., Young R.M., Swagell C.D., Barnes M., Burton S.C., Ward W.K., Heslop K.R., Shadforth S., van Daal A., Morris C.P. The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia. Schizophr. Res. 2005, 73:31-37.
17. Lewis C.M., Levinson D.F., Wise L.H., DeLisi L.E., Straub R.E., Hovatta I., Williams N.M., Schwab S.G., Pulver A.E., Faraone S.V., Brzustowicz L.M., Kaufmann C.A., Garver D.L., Gurling H.M., Lindholm E., Coon H., Moises H.W., Byerley W., Shaw S.H., Mesen A., Sherrington R., O'Neill F.A., Walsh D., Kendler K.S., Ekelund J., Paunio T., Lonnqvist J., Peltonen L., O'Donovan M.C., Owen M.J., Wildenauer D.B., Maier W., Nestadt G., Blouin J.L., Antonarakis S.E., Mowry B.J., Silverman J.M., Crowe R.R., Cloninger C.R., Tsuang M.T., Malaspina D., Harkavy-Friedman J.M., Svrakic D.M., Bassett A.S., Holcomb J., Kalsi G., McQuillin A., Brynjolfson J., Sigmundsson T., Petursson H., Jazin E., Zoega T., Helgason T. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am. J. Hum. Genet. 2003, 73:34-48.
18. Li Z., Zhang Z., He Z., Tang W., Li T., Zeng Z., He L., Shi Y. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis. Cell Res. 2009, 19:519-523. (http://analysis.bio-x.cn).
19. Lieberman J.A. Dopamine partial agonists: a new class of antipsychotic. CNS Drugs 2004, 18:251-267.
20. Lin P.I., Vance J.M., Pericak-Vance M.A., Martin E.R. No gene is an island: the flip-flop phenomenon. Am. J. Hum. Genet. 2007, 80:531-538.
21. Miyamoto S., Duncan G.E., Marx C.E., Lieberman J.A. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs. Mol. Psychiatry 2005, 10:79-104.
22. Monakhov M., Golimbet V., Abramova L., Kaleda V., Karpov V. Association study of three polymorphisms in the dopamine D2 receptor gene and schizophrenia in the Russian population. Schizophr. Res. 2008, 100:302-307.
23. Noble E.P. D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2003, 116B:103-125.
24. Seeman P., Kapur S. Schizophrenia: more dopamine, more D2 receptors. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:7673-7675.
25. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005, 15:97-98.
26. Tunbridge E.M, Harrison P.J., Weinberger D.R. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol. Psychiatry 2006, 60:141-151.
27. Xu H., Kellendonk C.B., Simpson E.H., Keilp J.G., Bruder G.E., Polan H.J., Kandel E.R., Gilliam T.C. DRD2 C957T polymorphism interacts with the COMT Val158Met polymorphism in human working memory ability. Schizophr. Res. 2007, 90:104-107.
28. Zhang Y., Bertolino A., Fazio L., Blasi G., Rampino A., Romano R., Lee M.L., Xiao T., Papp A., Wang D., Sadee W. Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:20552-20557.